Phenylketonuria Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 17
SKU : PH2150
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the Phenylketonuria Treatment Market ?
Phenylketonuria Treatment Market is expected to grow at a CAGR of 9.46% during the forecast period 2024-2031.
Who are the key players in Phenylketonuria Treatment Market ?
Major players are BioMarin, SOM Innovation Biotech SL, Homology Medicines, Inc., Par Pharmaceutical, PTC Therapeutics, and Synlogic, Inc.
Related Reports
pharmaceuticalsCystinuria Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 September 22
Starting from
$4350
pharmaceuticalsHematuria Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 March 04
Starting from
$4350
pharmaceuticalsSpinal Stenosis Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 December 19
Starting from
$4350
pharmaceuticalsPorphyria Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 January 19
Starting from
$4350
pharmaceuticalsPresbyopia Treatment Market Size, Share, Industry, Forecast and Demand (2023-2030)
Published: 2024 March 08
Starting from
$4350
pharmaceuticalsPenile Cancer Treatment Market Size, Share, Forecast and Outlook (2023-2030)
Published: 2023 September 26
Starting from
$4350